1例低分子肝素钙诱导血小板减少症的药学监护

摘要

目的 为临床药师参与低分子肝素钙诱导的血小板减少症患者的药物治疗提供参考.方法 临床药师对1例使用低分子肝素钙过程中出现进行性血小板减少的慢性喘息性支气管炎急性加重伴慢性肺源性心脏病患者进行药学监护,协助临床医生进行不良反应处理及治疗药物选择.结果 医生采纳临床药师建议,患者血小板逐渐恢复,未出现血栓事件.结论 临床药师参与低分子肝素钙诱导血小板减少的管理,能有效改善患者预后,保障患者的用药安全.%Objective To provide reference for clinical pharmacists participating in pharmacotherapy of low molecular weight heparin calium-induced thrombocytopenia.Methods Clinical pharmacists carried out pharmaceutical care for a patient with chronic cor pulmonale with acute exacerbation of chronic asthmatic bronchitis in the use of low molecular weight heparin calium,who developed progressive thrombocytopenia,and helped clinicians to manage adverse reaction and select subsequent treatment drug.Results The suggestions were adopted by clinicians.The platelets of patients gradually recovercd without thrombosis events.Condusion Participation of clinical pharmacists in the treatment of low molecular weight heparin calium induced-thrombocytopenia can effectively improve the prognosis of patients and ensure the safety in drug use.